Biotechnology
Manufacturing
Technology

Illumina

$302.29
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$2.76 (-0.90%) Today
$0.00 (0.00%) As of 4:41 PM EDT after-hours

Why Robinhood?

You can buy or sell Illumina and other stocks, options, ETFs, and crypto commission-free!

About ILMN

Illumina, Inc. engages in the development and manufacture of integrated systems for the analysis of genetic variation and function. It operates through the Core Illumina and Consolidated Variable Interest Entity segments (VIE). Read More The Core Illumina segments serve customers in the research, clinical and applied markets, and enable the adoption of genomic solutions. The Consolidated VIE segment includes activities of GRAIL and Helix. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Employees
7,300
Headquarters
San Diego, California
Founded
1998
Market Cap
44.84B
Price-Earnings Ratio
52.85
Dividend Yield
0.00
Average Volume
1.03M
High Today
$306.90
Low Today
$300.52
Open Price
$305.17
Volume
3.52M
52 Week High
$380.76
52 Week Low
$268.62

Collections

Biotechnology
Manufacturing
Technology
Pharmaceutical
Health

ILMN News

Washington PostJul 12

Ford, Milacron rise; Illumina, US Xpress fall

1,185
CNBCJul 12

Stocks making the biggest moves midday: Johnson & Johnson, Stitch Fix, Illumina, Merck & more

1,827
BenzingaJul 12

BofA Double Downgrades Illumina After Thursday's 'Big Miss'

2,299

ILMN Earnings

$1.01
$1.21
$1.40
$1.60
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Available Jul 29, After Hours

Popular Stocks

More ILMN News

BenzingaJul 12

What Caused The Opening Gap In Illumina Stock?

905
MarketWatchJul 12

Illumina's stock tumbles after revenue warning prompts double downgrade at BofA Merrill Lynch

441
Barron'sJul 12

Illumina Stock Is Plummeting but Analysts Still Favor Genome Company

655
BenzingaJul 12

Illumina Shares Slammed On Guidance Warning

301
Wall Street JournalJul 11

Illumina Stock Declines as Company Lowers Revenue Outlook

395
CNBCJul 11

Illumina plunges after slashing revenue expectations

611
MarketWatchJul 11

Illumina stock plunges more than 14% after genetics company lowers guidance

1,132
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.